{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:46:29Z","timestamp":1777927589565,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jinf.2019.06.009","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:17:57Z","timestamp":1561105077000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice"],"prefix":"10.1016","volume":"79","author":[{"given":"Silke","family":"Schelenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riina","family":"Rautemaa-Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini J.","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Enoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christianne","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir G.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit","family":"Muller-Pebody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jinf.2019.06.009_bib0001","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET)","volume":"50","author":"Pappas Peter","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.06.009_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jinf.2016.10.005","article-title":"Estimating the burden of invasive and serious fungal disease in the United Kingdom","volume":"74","author":"Pegorie","year":"2017","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.jinf.2019.06.009_bib0003","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi (Basel, Switzerland)"},{"issue":"11","key":"10.1016\/j.jinf.2019.06.009_bib0004","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.jinf.2019.06.009_bib0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","article-title":"Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment","volume":"31","author":"Vanderbeke","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2019.06.009_bib0006","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(15)70006-X","article-title":"British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases","volume":"15","author":"Schelenz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2019.06.009_bib0007","series-title":"Candida auris","year":"2017"},{"issue":"2","key":"10.1016\/j.jinf.2019.06.009_bib0008","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s40588-017-0061-y","article-title":"What can the clinical mycology laboratory do for clinicians today and tomorrow?","volume":"4","author":"Mourad","year":"2017","journal-title":"Curr Clin Microbiol Rep"},{"key":"10.1016\/j.jinf.2019.06.009_bib0009","article-title":"UK Standards for Microbiology Investigations","volume":"B 57","year":"2018"},{"issue":"1","key":"10.1016\/j.jinf.2019.06.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00029-17","article-title":"Candida auris: a review of the literature","volume":"31","author":"Jeffery-Smith","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.jinf.2019.06.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jinf.2019.06.009_bib0012","article-title":"Candida auris: the recent emergence of a multidrug-resistant fungal pathogen","author":"Forsberg","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.jinf.2019.06.009_bib0013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold Nathan","year":"2017","journal-title":"Infect Drug Resist"},{"issue":"suppl_3","key":"10.1016\/j.jinf.2019.06.009_bib0014","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.06.009_bib0015","series-title":"English surveillance programme for antimicrobial utilisation and resistance","year":"2016"},{"issue":"2","key":"10.1016\/j.jinf.2019.06.009_bib0016","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jinf.2008.12.006","article-title":"Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit","volume":"58","author":"Schelenz","year":"2009","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jinf.2019.06.009_bib0017","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.06.009_bib0018","article-title":"UK Standards for Microbiology Investigations","volume":"B 37(9.1)","year":"2018"},{"key":"10.1016\/j.jinf.2019.06.009_bib0019","article-title":"UK Standards for Microbiology Investigations","volume":"B 26(6.2)","year":"2018"},{"key":"10.1016\/j.jinf.2019.06.009_bib0020","article-title":"UK Standards for Microbiology Investigations","volume":"B 41(8.6)","year":"2018"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2019.06.009_bib0021","doi-asserted-by":"crossref","first-page":"i13","DOI":"10.1093\/jac\/dkm427","article-title":"Issues in antifungal susceptibility testing","volume":"61","author":"Johnson Elizabeth","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.06.009_bib0022","series-title":"Mycology Reference Laboratory: Service User Handbook","year":"2014"},{"issue":"10","key":"10.1016\/j.jinf.2019.06.009_bib0023","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2019.06.009_bib0024","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij Paul","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2019.06.009_bib0025","series-title":"Manual of Clinical Microbiology","first-page":"2255","article-title":"Susceptibility test methods: yeasts and filamentous fungi","author":"Johnson Elizabeth","year":"2015"},{"key":"10.1016\/j.jinf.2019.06.009_bib0026","series-title":"CLSI Supplement M60","article-title":"Performance standards for antifungal susceptibility testing of yeast","year":"2017"},{"key":"10.1016\/j.jinf.2019.06.009_bib0027","series-title":"CLSI Supplement M59","article-title":"Epidemiological cutoff values for antifungal susceptibility testing","year":"2018"},{"key":"10.1016\/j.jinf.2019.06.009_bib0028","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Antifungal susceptibility testing (AFST). Available athttp:\/\/www.eucast.org\/antifungal_susceptibility_testing_afst\/. Accessed 24 October 2018, 2018."},{"issue":"9","key":"10.1016\/j.jinf.2019.06.009_bib0029","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of aspergillus PCR for testing serum and plasma: a study by the european aspergillus PCR initiative","volume":"53","author":"White","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.06.009_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dky360","article-title":"Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital","author":"Rautemaa-Richardson","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"14","key":"10.1016\/j.jinf.2019.06.009_bib0031","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa1714373","article-title":"A Candida auris outbreak and its control in an intensive care setting","volume":"379","author":"Eyre David","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2019.06.009_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2018.07.012","article-title":"Assessing routine diagnostic methods for detecting Candida auris in England","author":"Sharp","year":"2018","journal-title":"J Infect"},{"issue":"suppl_1","key":"10.1016\/j.jinf.2019.06.009_bib0033","doi-asserted-by":"crossref","first-page":"i12","DOI":"10.1093\/jac\/dkx029","article-title":"Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations","volume":"72","author":"Stott Katharine","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"suppl_1","key":"10.1016\/j.jinf.2019.06.009_bib0034","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1093\/jac\/dkx447","article-title":"Overview of antifungal dosing in invasive candidiasis","volume":"73","author":"Pea","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.06.009_bib0035","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Medicines Information: SPC & PILs. Available athttp:\/\/www.mhra.gov.uk\/spc-pil\/index.htm. Accessed 18 March 2019, 2019."},{"issue":"6","key":"10.1016\/j.jinf.2019.06.009_bib0036","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van der Linden Jan","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2019.06.009_bib0037","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/jmm.0.000612","article-title":"An investigation of antifungal stewardship programmes in England","volume":"66","author":"Micallef","year":"2017","journal-title":"J Med Microbiol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319301902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319301902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:27:49Z","timestamp":1759008469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319301902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0163445319301902"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.06.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}